The Leukemia & Lymphoma Society
1311 Mamaroneck Avenue
193 articles with The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society and Rally Foundation for Childhood Cancer Research Announce Collaboration to Fight Pediatric Leukemia
The Leukemia & Lymphoma Society and Rally Foundation for Childhood Cancer Research announced that they are teaming up to fund a $400,000 research grant to fight pediatric acute myeloid leukemia, a disease that has seen limited advancement in therapies over the last several decades.
The Hairy Cell Leukemia Foundation and The Leukemia & Lymphoma Society Join Forces to Find New Therapies for Patients with this Rare Blood Cancer
The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society (LLS) announced today they are teaming up to support a research grants program of up to $10 million over five years, to build a more comprehensive understanding of hairy cell leukemia (HCL), develop better therapies and optimize outcom
Study in Nature Medicine Shows Superior Outcomes for Patients in The Leukemia & Lymphoma Society's Paradigm-Shifting Beat AML Clinical Trial
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine
Canada's blood cancer community to unite at Light The Night, Take Back The Light virtual event amid pandemic
More than 50, 000 people from across the country are expected to take part in Light The Night, Take Back The Light – an annual flagship event hosted by The Leukemia & Lymphoma Society of Canada.
Loblaw Companies Limited step up in a time of crisis to help support Canadians affected by a blood cancer
The Leukemia & Lymphoma Society of Canada and Loblaw Companies Limited are pleased to announce this year's Give a Little, Help a Lot Light The Night campaign has raised $281,874 for Canadians affected by a blood cancer through in-store fundraising at its Superstore and Extra Food locations across the Western provinces and Ontario . Funds
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt "Patient-First" Policy Agenda
A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort by releasing their top priorities for the next Administration.
Amanda Yancey named Executive Director for The Leukemia & Lymphoma Society's Georgia - South Carolina Region
Amanda Yancey has been named the executive director of The Leukemia & Lymphoma Society's Georgia - South Carolina Region, as of September 1, 2020.
The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
LLS's Innovative Beat AML Precision Medicine Clinical Trial Framework Will Expand to Test Treatment for Critically Ill Blood Cancer Patients with the Coronavirus
CURE® Speaking Out Video Series Supports Blood Cancer Awareness Month and World Lymphoma Awareness Day
Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.
PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia
LLS partners with PRA to help manage industry-first LLS PedAL master clinical trial to address the urgent need for new treatments for pediatric acute leukemia [03-September-2020] RYE BROOK, N.Y. and RALEIGH, N.C. , Sept. 3, 2020 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a
Global leader in fighting blood cancer, The Leukemia & Lymphoma Society, remains laser-focused on its mission amidst pandemic
Communities Nationwide Remain Laser-Focused on Helping Cancer Patients Who Can't Wait For Pandemic to Go Away
The Leukemia & Lymphoma Society Announces Winners of 2020 Man & Woman of the Year Fundraising Competition
The Leukemia & Lymphoma Society Today Announces a Collaboration with the National Cancer Institute and Children's Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia
New Study to Test Precision Medicine Treatments to Improve Outcomes for Children with Leukemia
In a world of uncertainty, one thing is for sure — cancer doesn't stop during a global crisis.
The Leukemia & Lymphoma Society And Partners Commit $4.5 Million For Blood Cancer Patients Impacted By COVID-19
LLS Sets Goal of Raising $10 Million from Partners and Donors for New LLS COVID-19 Patient Financial Aid Program Launching April 1
29 Patient Organizations Urge Lawmakers to Take Bold, Immediate Action to Protect Those Most Vulnerable to COVID-19
Organizations representing millions of patients diagnosed with serious health conditions urge the U.S. Senate to immediately pass the U.S. House-approved coronavirus bill and take additional critical steps..
Short-Term Health Plans Leave Patients Vulnerable to Major Medical Bills, According to New Research from The Leukemia & Lymphoma Society
LLS cautions consumers to be wary of short-term plans and urges state and federal policymakers to protect patients
What do the Columbia Center in Seattle, Capella Tower in Minneapolis and Salesforce Tower in San Francisco have in common? They are all iconic buildings with 1,000 or more steps, and they are sites for The Leukemia & Lymphoma Society's latest fundraising innovation – BIG CLIMB.
The 18th year of partnership marks the largest donation to date by Burlington to help those affected by blood cancer
Walgreens, Susan G. Komen and The Leukemia & Lymphoma Society Collaborate to Support Research in Tough-to-Treat Cancers and Increase Access to Care
$25M, multi-year commitment builds on Walgreens efforts to improve the health and well-being of people living with cancer nationwide